Pfizer repels Covid-19 sales tumble to raise 2026 guidance

Pfizer repels Covid-19 sales tumble to raise 2026 guidance is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Source: Pharmaceutical Technology